StonvexLoading…
StonvexCore line items from TRDA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $25.42M | $210.78M | $129.01M |
Operating Income | $-157.90M | $47.01M | $-3.16M |
Net Income | $-143.75M | $65.63M | $-6.68M |
EPS (Diluted) | $-3.47 | $1.68 | $-0.20 |
Total Assets | $377.38M | $526.32M | $469.19M |
Total Liabilities | $71.25M | $97.64M | $226.83M |
Cash & Equivalents | $90.39M | $101.21M | $67.60M |
Free Cash Flow OCF − CapEx | $-129.55M | $-44.72M | $134.19M |
Shares Outstanding | 38.28M | 37.57M | 33.44M |